๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

An intragastric balloon in the treatment of obese individuals with metabolic syndrome: A randomized controlled study

โœ Scribed by Fuller, Nicholas R. (author);Pearson, Suzanne (author);Lau, Namson S. (author);Wlodarczyk, John (author);Halstead, Michael B. (author);Tee, Hoi Poh (author);Chettiar, Raman (author);Kaffes, Arthur J. (author)

Book ID
121866657
Publisher
Nature Publishing Group
Year
2013
Tongue
English
Weight
882 KB
Volume
21
Category
Article
ISSN
1930-7381

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Moxonidine in the treatment of overweigh
Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study
โœ Sharma, A M; Wagner, T; Marsalek, P ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› Nature Publishing Group ๐ŸŒ English โš– 132 KB

Moxonidine is a centrally active imidazoline receptor agonist that effectively lowers blood pressure and has been shown to have beneficial effects on lipid and carbohydrate metabolism. We assessed the efficacy of moxonidine in a postmarketing surveillance study (CAMUS) conducted in 772 practices in